Knowledge Center
Patent / Aug 04, 2022
Inhaled ivermectin
Source:
US 20220241307
The present invention contemplates the use of inhaled ivermectin for use in various viruses and parasitic infections (treatment and/or prophylaxis) that are present or manifest in the lungs or respiratory tract. Exemplary dosing, formulations, devices, and processing techniques are also disclosed herein.
Also in the Knowledge Center
/ Jan 26, 2023
Webinar - Accelerating the Adoption of Continuous Tableting: The Responsibility of a CDMO
Read more
Scientific Article
/ Feb 22, 2017
Webinar - Development by Design: Hovione’s Approach to Spray Drying Process Development
Read more
Scientific Article
/ Feb 22, 2017
Webinar - Physical Characterization of Drugs: avoiding surprises during late development
Read more
Scientific Article